Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors-Hit to lead exploration

被引：17

作者：

Oza, Vibha ^{[1
]}

Ashwell, Susan ^{[1
]}

Brassil, Patrick ^{[1
]}

Breed, Jason ^{[2
]}

Deng, Chun ^{[1
]}

Ezhuthachan, Jay ^{[1
]}

Haye, Heather ^{[2
]}

Horn, Candice ^{[1
]}

Janetka, James ^{[1
]}

Lyne, Paul ^{[1
]}

Newcombe, Nicholas ^{[2
]}

Otterbien, Ludo ^{[2
]}

Pass, Martin ^{[2
]}

Read, Jon ^{[2
]}

Roswell, Sian ^{[2
]}

Su, Mei ^{[1
]}

Toader, Dorin ^{[1
]}

Yu, Dingwei ^{[1
]}

Yu, Yan ^{[1
]}

Valentine, Anna ^{[2
]}

Webborn, Peter ^{[2
]}

White, Ann ^{[2
]}

Zabludoff, Sonya ^{[1
]}

Zheng, Xiaolan ^{[1
]}

机构：

[1] AstraZeneca R&D Boston, Waltham, MA 02451 USA

[2] AstraZeneca R&D Alderley Pk, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 17期

关键词：

Triazolones; CHK1; Checkpoint Kinase inhibitors; PROTEIN-KINASE; UCN-01;

D O I：

10.1016/j.bmcl.2010.07.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Checkpoint Kinase-1 (Chk1, CHK1, CHEK1) is a Ser/Thr protein kinase that mediates cellular responses to DNA-damage. A novel class of Chk1 inhibitors, triazoloquinolones/triazolones (TZ's) was identified by high throughput screening. The optimization of these hits to provide a lead series is described. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5133 / 5138

页数：6

共 50 条

[1] Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors
Snow, Roger J.
Abeywardane, Asitha
Campbell, Scot
Lord, John
Kashem, Mohammed A.
Khine, Hnin Hnin
King, Josephine
Kowalski, Jennifer A.
Pullen, Steven S.
Roma, Teresa
Roth, Gregory P.
Sarko, Christopher R.
Wilson, Noel S.
Winters, Michael P.
Wolak, John P.
Cywin, Charles L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3660 - 3665
[2] Discovery of novel Rho kinase inhibitors: Hit generation and lead optimization
Alexander, Brian G.
Pireddu, Roberta
Sun, Nan N.
Yu, Huidong
Forinash, Kara D.
Martin, Matthew P.
Schonbrunn, Ernst
Guida, Wayne C.
Sebti, Said M.
Lawrence, Nicholas J.
CANCER RESEARCH, 2011, 71
[3] Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors
Oza, Vibha
Ashwell, Susan
Brassil, Patrick
Breed, Jason
Ezhuthachan, Jaychandran
Deng, Chun
Grondine, Michael
Horn, Candice
Liu, DongFang
Lyne, Paul
Newcombe, Nicholas
Pass, Martin
Read, Jon
Su, Mei
Toader, Dorin
Yu, Dingwei
Yu, Yan
Zabludoff, Sonya
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2330 - 2337
[4] Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors
Janetka, James W.
Almeida, Lynsie
Ashwell, Susan
Brassil, Patrick J.
Daly, Kevin
Deng, Chun
Gero, Thomas
Glynn, Roberta E.
Horn, Candice L.
Ioannidis, Stephanos
Lyne, Paul
Newcombe, Nicholas J.
Oza, Vibha B.
Pass, Martin
Springer, Stephanie K.
Su, Mei
Toader, Dorin
Vasbinder, Melissa M.
Yu, Dingwei
Yu, Yan
Zabludoff, Sonya D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4242 - 4248
[5] MEDI 356-Hit to lead account of the discovery of a new class of inhibitors of Pim-2 kinase
Prokopowicz, Anthony S., III
Morwick, Tina
Cywin, Charles L.
Qian, Kevin
Mao, Wang
Wolak, John P.
Peng, Charlene
Kashem, Mohammed A.
Li, Jun
Wang, Lian
Jakes, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[6] Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase
Morwick, Tina
Buettner, Frank H.
Cywin, Charles L.
Dahmann, Georg
Hickey, Eugene
Jakes, Scott
Kaplita, Paul
Kashem, Mohammed A.
Kerr, Steven
Kugler, Stanley
Mao, Wang
Marshall, Daniel
Paw, Zofia
Shih, Cheng-Kon
Wu, Frank
Young, Erick
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (02) : 759 - 777
[7] Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1
Gazzard, Lewis
Appleton, Brent
Chapman, Kerry
Chen, Huifen
Clark, Kevin
Drobnick, Joy
Goodacre, Simon
Halladay, Jason
Lyssikatos, Joseph
Schmidt, Stephen
Sideris, Steve
Wiesmann, Christian
Williams, Karen
Wu, Ping
Yen, Ivana
Malek, Shiva
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (24) : 5704 - 5709
[8] Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1
Gazzard, Lewis J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[9] Hit to Lead Account of the Discovery of a New Class of Inhibitors of Pim Kinases and Crystallographic Studies Revealing an Unusual Kinase Binding Mode
Qian, Kevin
Wang, Lian
Cywin, Charles L.
Farmer, Bennett T., II
Hickey, Eugene
Homon, Carol
Jakes, Scott
Kashem, Mohammed A.
Lee, George
Leonard, Scott
Li, Jun
Magboo, Ronald
Mao, Wang
Pack, Edward
Peng, Charlene
Prokopowicz, Anthony, III
Welzel, Morgan
Wolak, John
Morwick, Tina
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (07) : 1814 - 1827
[10] Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists
Yamada, Toru
Mihara, Kousuke
Ueda, Taichi
Yamauchi, Daisuke
Shimizu, Masaya
Ando, Azusa
Mayumi, Kei
Nakata, Zenzaburo
Mikamiyama, Hidenori
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (13) : 11197 - 11208

← 1 2 3 4 5 →